Woodline Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
Woodline Partners's DXCM Position: Q3 2026 in Review
Woodline Partners increased its DexCom (DXCM) stake by 5.1% in Q3 2026, buying an estimated $2.27M and bringing the position to 564,020 shares worth $48.7M. The position accounts for 0.15% of the portfolio, ranked #171.
Woodline Partners first reported a position in DXCM in Q4 2019 and has held it in 24 quarters since. The position peaked at $63.3M in Q4 2024. 1,056 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.
- Woodline Partners held 564,020 shares of DexCom worth $48.7M as of Q3 2026.
- Woodline Partners bought 27,318 DexCom shares in Q3 2026, an estimated $2.27M.
- DexCom made up 0.15% of Woodline Partners's portfolio in Q3 2026, its #171 holding.
- Woodline Partners first reported a position in DexCom in Q4 2019 and has held it in 24 quarters since.
- Woodline Partners's DexCom position peaked at $63.3M in Q4 2024.
- 1,056 funds tracked by Wall St. Rank held DexCom as of Q3 2026.
Based on Woodline Partners's 13F filing for Q3 2026, filed 16 Nov 2026.